Neural cell replacement therapy - Ophiuchus Technologies

Drug Profile

Neural cell replacement therapy - Ophiuchus Technologies

Alternative Names: Autologous neural stem cell therapy - Ophiuchus Technologies; Autologous neural stem cells - Ophiuchus Technologies; Directly reprogrammed neural stem cells - Ophiuchus Technologies; DrSC™ Neural

Latest Information Update: 06 Apr 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Ophiuchus Technologies
  • Developer Federal Medical and Biological Agency of Russia; Ophiuchus Technologies
  • Class Neuroprotectants; Stem cell therapies
  • Mechanism of Action Cell replacements; Neurogenesis stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Phase I/II Spinal cord injuries
  • Preclinical Brain injuries

Most Recent Events

  • 06 Apr 2017 Phase-I/II development for Spinal cord injuries is ongoing in Russia (Intrathecal), (Intraspinal)
  • 01 Jun 2014 Phase-I/II clinical trials in Spinal cord injuries in Russia (Intraspinal, Intrathecal)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top